Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.51p
   
  • Change Today:
    -0.013p
  • 52 Week High: 7.15
  • 52 Week Low: 0.50
  • Currency: UK Pounds
  • Shares Issued: 1,513.39m
  • Volume: 3,094,769
  • Market Cap: £7.76m
  • RiskGrade: 429
  • Beta: 0.04

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Erik Kristian Lium, Lorenzo Gallon, James Renwick McCullough

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 0.51p
Change Today -0.013p
% Change -2.38 %
52 Week High 7.15
52 Week Low 0.50
Volume 3,094,769
Shares Issued 1,513.39m
Market Cap £7.76m
Beta 0.04
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.84% below the market average31.84% below the market average31.84% below the market average31.84% below the market average31.84% below the market average
30.23% below the sector average30.23% below the sector average30.23% below the sector average30.23% below the sector average30.23% below the sector average
Price Trend
97.83% below the market average97.83% below the market average97.83% below the market average97.83% below the market average97.83% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
25.14% above the market average25.14% above the market average25.14% above the market average25.14% above the market average25.14% above the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average

Verici DX Dividends

No dividends found

Trades for 11-Aug-2025

Time Volume / Share Price
15:26 3,331 @ 0.50p
13:00 200,000 @ 0.50p
12:33 1,000,000 @ 0.50p
12:21 1,000,000 @ 0.50p
11:19 396,033 @ 0.50p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page